» Articles » PMID: 4784885

Growth of Pasteurella Multocida in Vaccinated and Normal Mice

Overview
Journal Infect Immun
Date 1973 Dec 1
PMID 4784885
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Specific pathogen-free CD-1 mice are highly susceptible to infection by Pasteurella multocida strain 5A whether introduced intravenously, intraperitoneally, subcutaneously, or aerogenically. The growth of the challenge organism in the blood, liver, spleen, lung, and peritoneal cavity was quantitated hourly for up to 12 h. Unvaccinated mice died 9 to 12 h after intravenous challenge due to the uncontrolled growth of the organism in all tissues tested. The rate of removal of the bacteria from the blood and of phagocytosis by peritoneal macrophages was extremely slow. In the absence of specific opsonins, more than 90% of the unopsonized challenge inoculum remained in the extracellular growth phase throughout the challenge period. Vaccination of mice with two doses of 10(8) heat-killed (60 C for 60 min) P. multocida given 7 days apart protected the mice against 100 to 1,000 lethal challenge doses. Survival data and growth curves obtained for both actively and passively immunized mice indicated that a humorally mediated immune mechanism was involved. Peak resistance to challenge occurred 21 to 28 days after the mice received the second dose of antigen, and this correlated with an 8- to 16-fold increase in specific agglutinin titers over the same time. Resistance to aerogenic challenge by vaccinated mice was less effective than when other routes of infection were used. The significance of these findings is discussed.

Citing Articles

Evaluation of the immunogenic properties of the recombinant Histophilus somni outer membrane protein 40 kDa (rOMP40).

Bajzert J, Szydlowska K, Jawor P, Wawrzyniak A, Pisarek M, Stefaniak T BMC Vet Res. 2022; 18(1):409.

PMID: 36401280 PMC: 9673221. DOI: 10.1186/s12917-022-03515-x.


NEGATIVE REGULATORY EFFECTS OF PHOSPHATIDYLINOSITOL3-KINASE PATHWAY ON PHAGOCYTOSIS AND MACROPINOCYTOSIS IN BOVINE MONOCYTES.

Ammari M, Harris A, Stokes J, Bailey R, Pinchuk L J Vet Med Res. 2015; 1(2).

PMID: 25893219 PMC: 4399709.


Protective immunity conferred by attenuated aroA derivatives of Pasteurella multocida B:2 strains in a mouse model of hemorrhagic septicemia.

Tabatabaei M, Liu Z, Finucane A, Parton R, Coote J Infect Immun. 2002; 70(7):3355-62.

PMID: 12065473 PMC: 128070. DOI: 10.1128/IAI.70.7.3355-3362.2002.


Intranasal immunization of mice against Pasteurella multocida.

Smith R, Babiuk L, Stockdale P Infect Immun. 1981; 31(1):129-35.

PMID: 7216441 PMC: 351761. DOI: 10.1128/iai.31.1.129-135.1981.


Bactericidal activity of alveolar and peritoneal macrophages exposed in vitro to three strains of Pasteurella multocida.

Collins F, Niederbuhl C, Campbell S Infect Immun. 1983; 39(2):779-84.

PMID: 6832820 PMC: 348017. DOI: 10.1128/iai.39.2.779-784.1983.


References
1.
Blanden R, Mackaness G, Collins F . Mechanisms of acquired resistance in mouse typhoid. J Exp Med. 1966; 124(4):585-600. PMC: 2138250. DOI: 10.1084/jem.124.4.585. View

2.
Alls A, APPLETON G, Ipson J . A bird-contact method of challenging turkeys with Pasteurella multocida. Avian Dis. 1970; 14(1):172-8. View

3.
CARTER G . Pasteurellosis: Pasteurella multocida and Pasteurella hemolytica. Adv Vet Sci. 1967; 11:321-79. View

4.
HEDDLESTON K, Rebers P . Pasteurella multocida: immune response in chicks and mice. Proc Annu Meet U S Anim Health Assoc. 1969; 73:280-4. View

5.
Collins F . Mechanisms in antimicrobial immunity. J Reticuloendothel Soc. 1971; 10(1):58-99. View